Michelle Griffin

Michelle Griffin is currently the Director at Adaptive Biotechnologies. Prior to their current position, Michelle held various positions at several companies, such as Acting Chief Executive Officer at Qwell Pharmaceuticals, Inc., EVP Operations and Chief Financial Officer at OncoGenex Pharmaceuticals, and SVP, Chief Operating Officer at Trubion Pharmaceuticals, Inc. Michelle has also been a Board Member for Sonus Pharmaceuticals, Inc. and Acer Therapeutics Inc. In 2018, they were the Chair of the Board of Directors for Universal Cells before it was acquired by Astellas.